Letters
Volume 28—2022
Volume 28, Number 12—December 2022

Hand, Foot, and Mouth Disease as Differential Diagnosis of Monkeypox, Germany, August 2022
EID | Fathi A, Schmiedel S. Hand, Foot, and Mouth Disease as Differential Diagnosis of Monkeypox, Germany, August 2022. Emerg Infect Dis. 2022;28(12):2586. https://doi.org/10.3201/eid2812.221487 |
---|---|
AMA | Fathi A, Schmiedel S. Hand, Foot, and Mouth Disease as Differential Diagnosis of Monkeypox, Germany, August 2022. Emerging Infectious Diseases. 2022;28(12):2586. doi:10.3201/eid2812.221487. |
APA | Fathi, A., & Schmiedel, S. (2022). Hand, Foot, and Mouth Disease as Differential Diagnosis of Monkeypox, Germany, August 2022. Emerging Infectious Diseases, 28(12), 2586. https://doi.org/10.3201/eid2812.221487. |
Volume 28, Number 8—August 2022

Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance
EID | Freitas A, Pezzi L, Cavalcanti L, Simon F. Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance. Emerg Infect Dis. 2022;28(8):1736-1737. https://doi.org/10.3201/eid2808.220558 |
---|---|
AMA | Freitas A, Pezzi L, Cavalcanti L, et al. Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance. Emerging Infectious Diseases. 2022;28(8):1736-1737. doi:10.3201/eid2808.220558. |
APA | Freitas, A., Pezzi, L., Cavalcanti, L., & Simon, F. (2022). Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance. Emerging Infectious Diseases, 28(8), 1736-1737. https://doi.org/10.3201/eid2808.220558. |
Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance (Response)
EID | Anzinger JJ. Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance (Response). Emerg Infect Dis. 2022;28(8):1737-1738. https://doi.org/10.3201/eid2808.221006 |
---|---|
AMA | Anzinger JJ. Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance (Response). Emerging Infectious Diseases. 2022;28(8):1737-1738. doi:10.3201/eid2808.221006. |
APA | Anzinger, J. J. (2022). Seroprevalence of Chikungunya Virus, Jamaica, and New Tools for Surveillance (Response). Emerging Infectious Diseases, 28(8), 1737-1738. https://doi.org/10.3201/eid2808.221006. |
Imported Monkeypox from International Traveler, Maryland, USA, 2021
EID | Minhaj FS, Rao AK, McCollum AM. Imported Monkeypox from International Traveler, Maryland, USA, 2021. Emerg Infect Dis. 2022;28(8):1738. https://doi.org/10.3201/eid2808.220726 |
---|---|
AMA | Minhaj FS, Rao AK, McCollum AM. Imported Monkeypox from International Traveler, Maryland, USA, 2021. Emerging Infectious Diseases. 2022;28(8):1738. doi:10.3201/eid2808.220726. |
APA | Minhaj, F. S., Rao, A. K., & McCollum, A. M. (2022). Imported Monkeypox from International Traveler, Maryland, USA, 2021. Emerging Infectious Diseases, 28(8), 1738. https://doi.org/10.3201/eid2808.220726. |
Imported Monkeypox from International Traveler, Maryland, USA, 2021 (Response)
EID | Costello V, Sowash M, Gaur A, Cardis M, Pasieka H, Wortmann G, et al. Imported Monkeypox from International Traveler, Maryland, USA, 2021 (Response). Emerg Infect Dis. 2022;28(8):1739. https://doi.org/10.3201/eid2808.220830 |
---|---|
AMA | Costello V, Sowash M, Gaur A, et al. Imported Monkeypox from International Traveler, Maryland, USA, 2021 (Response). Emerging Infectious Diseases. 2022;28(8):1739. doi:10.3201/eid2808.220830. |
APA | Costello, V., Sowash, M., Gaur, A., Cardis, M., Pasieka, H., Wortmann, G....Ramdeen, S. (2022). Imported Monkeypox from International Traveler, Maryland, USA, 2021 (Response). Emerging Infectious Diseases, 28(8), 1739. https://doi.org/10.3201/eid2808.220830. |
Volume 28, Number 6—June 2022

Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012–2020
EID | McNamara KX, Perz JF, Perkins KM. Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012–2020. Emerg Infect Dis. 2022;28(6):1303. https://doi.org/10.3201/eid2806.220520 |
---|---|
AMA | McNamara KX, Perz JF, Perkins KM. Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012–2020. Emerging Infectious Diseases. 2022;28(6):1303. doi:10.3201/eid2806.220520. |
APA | McNamara, K. X., Perz, J. F., & Perkins, K. M. (2022). Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012–2020. Emerging Infectious Diseases, 28(6), 1303. https://doi.org/10.3201/eid2806.220520. |
Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012‒2020 (response)
EID | Daniau C, Berger-Carbonne A, Cambau E. Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012‒2020 (response). Emerg Infect Dis. 2022;28(6):1303-1304. https://doi.org/10.3201/eid2806.220686 |
---|---|
AMA | Daniau C, Berger-Carbonne A, Cambau E. Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012‒2020 (response). Emerging Infectious Diseases. 2022;28(6):1303-1304. doi:10.3201/eid2806.220686. |
APA | Daniau, C., Berger-Carbonne, A., & Cambau, E. (2022). Association of Healthcare and Aesthetic Procedures with Infections Caused by Nontuberculous Mycobacteria, France, 2012‒2020 (response). Emerging Infectious Diseases, 28(6), 1303-1304. https://doi.org/10.3201/eid2806.220686. |
Volume 28, Number 5—May 2022

Guillain-Barré Syndrome Associated with COVID-19 Vaccination
EID | Finsterer J, Scorza FA, Scorza CA. Guillain-Barré Syndrome Associated with COVID-19 Vaccination. Emerg Infect Dis. 2022;28(5):1079-1080. https://doi.org/10.3201/eid2805.212145 |
---|---|
AMA | Finsterer J, Scorza FA, Scorza CA. Guillain-Barré Syndrome Associated with COVID-19 Vaccination. Emerging Infectious Diseases. 2022;28(5):1079-1080. doi:10.3201/eid2805.212145. |
APA | Finsterer, J., Scorza, F. A., & Scorza, C. A. (2022). Guillain-Barré Syndrome Associated with COVID-19 Vaccination. Emerging Infectious Diseases, 28(5), 1079-1080. https://doi.org/10.3201/eid2805.212145. |
SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia
EID | Grassia JT, Markwalter CF, O’Meara WP, Taylor SM, Obala AA. SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia. Emerg Infect Dis. 2022;28(5):1080-1081. https://doi.org/10.3201/eid2805.220404 |
---|---|
AMA | Grassia JT, Markwalter CF, O’Meara WP, et al. SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia. Emerging Infectious Diseases. 2022;28(5):1080-1081. doi:10.3201/eid2805.220404. |
APA | Grassia, J. T., Markwalter, C. F., O’Meara, W. P., Taylor, S. M., & Obala, A. A. (2022). SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia. Emerging Infectious Diseases, 28(5), 1080-1081. https://doi.org/10.3201/eid2805.220404. |
Melioidosis in Children, Brazil, 1989–2019
EID | Behera B, Radhakrishnan A, Mohapatra S, Mishra B. Melioidosis in Children, Brazil, 1989–2019. Emerg Infect Dis. 2022;28(5):1081-1082. https://doi.org/10.3201/eid2805.211473 |
---|---|
AMA | Behera B, Radhakrishnan A, Mohapatra S, et al. Melioidosis in Children, Brazil, 1989–2019. Emerging Infectious Diseases. 2022;28(5):1081-1082. doi:10.3201/eid2805.211473. |
APA | Behera, B., Radhakrishnan, A., Mohapatra, S., & Mishra, B. (2022). Melioidosis in Children, Brazil, 1989–2019. Emerging Infectious Diseases, 28(5), 1081-1082. https://doi.org/10.3201/eid2805.211473. |
Melioidosis in Children, Brazil, 1989–2019 (response)
EID | Lima R, Rolim D. Melioidosis in Children, Brazil, 1989–2019 (response). Emerg Infect Dis. 2022;28(5):1081-1082. https://doi.org/10.3201/eid2805.220479 |
---|---|
AMA | Lima R, Rolim D. Melioidosis in Children, Brazil, 1989–2019 (response). Emerging Infectious Diseases. 2022;28(5):1081-1082. doi:10.3201/eid2805.220479. |
APA | Lima, R., & Rolim, D. (2022). Melioidosis in Children, Brazil, 1989–2019 (response). Emerging Infectious Diseases, 28(5), 1081-1082. https://doi.org/10.3201/eid2805.220479. |
High-Dose Convalescent Plasma for Treatment of Severe COVID-19
EID | Focosi D, Casadevall A. High-Dose Convalescent Plasma for Treatment of Severe COVID-19. Emerg Infect Dis. 2022;28(5):1083. https://doi.org/10.3201/eid2805.220191 |
---|---|
AMA | Focosi D, Casadevall A. High-Dose Convalescent Plasma for Treatment of Severe COVID-19. Emerging Infectious Diseases. 2022;28(5):1083. doi:10.3201/eid2805.220191. |
APA | Focosi, D., & Casadevall, A. (2022). High-Dose Convalescent Plasma for Treatment of Severe COVID-19. Emerging Infectious Diseases, 28(5), 1083. https://doi.org/10.3201/eid2805.220191. |
High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response)
EID | De Santis GC, Calado RT. High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response). Emerg Infect Dis. 2022;28(5):1083-1084. https://doi.org/10.3201/eid2805.220363 |
---|---|
AMA | De Santis GC, Calado RT. High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response). Emerging Infectious Diseases. 2022;28(5):1083-1084. doi:10.3201/eid2805.220363. |
APA | De Santis, G. C., & Calado, R. T. (2022). High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response). Emerging Infectious Diseases, 28(5), 1083-1084. https://doi.org/10.3201/eid2805.220363. |
Volume 28, Number 3—March 2022

Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level
EID | Barr IG, Williams TC, Salimi V, Buchholz UJ. Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level. Emerg Infect Dis. 2022;28(3):764. https://doi.org/10.3201/eid2803.212438 |
---|---|
AMA | Barr IG, Williams TC, Salimi V, et al. Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level. Emerging Infectious Diseases. 2022;28(3):764. doi:10.3201/eid2803.212438. |
APA | Barr, I. G., Williams, T. C., Salimi, V., & Buchholz, U. J. (2022). Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level. Emerging Infectious Diseases, 28(3), 764. https://doi.org/10.3201/eid2803.212438. |
Volume 28, Number 2—February 2022

High Infection Attack Rate after SARS-CoV-2 Delta Surge, Chattogram, Bangladesh
EID | Hegde ST, Bhuiyan T, Akhtar M, Islam T, Hulse J, Khan Z, et al. High Infection Attack Rate after SARS-CoV-2 Delta Surge, Chattogram, Bangladesh. Emerg Infect Dis. 2022;28(2):491-492. https://doi.org/10.3201/eid2802.212417 |
---|---|
AMA | Hegde ST, Bhuiyan T, Akhtar M, et al. High Infection Attack Rate after SARS-CoV-2 Delta Surge, Chattogram, Bangladesh. Emerging Infectious Diseases. 2022;28(2):491-492. doi:10.3201/eid2802.212417. |
APA | Hegde, S. T., Bhuiyan, T., Akhtar, M., Islam, T., Hulse, J., Khan, Z....Qadri, F. (2022). High Infection Attack Rate after SARS-CoV-2 Delta Surge, Chattogram, Bangladesh. Emerging Infectious Diseases, 28(2), 491-492. https://doi.org/10.3201/eid2802.212417. |
Predictors of Nonseroconversion after SARS-CoV-2 Infection
EID | Davido B, Jaffal K, Annane D, Lawrence C, Gault E, De P. Predictors of Nonseroconversion after SARS-CoV-2 Infection. Emerg Infect Dis. 2022;28(2):492-493. https://doi.org/10.3201/eid2802.211971 |
---|---|
AMA | Davido B, Jaffal K, Annane D, et al. Predictors of Nonseroconversion after SARS-CoV-2 Infection. Emerging Infectious Diseases. 2022;28(2):492-493. doi:10.3201/eid2802.211971. |
APA | Davido, B., Jaffal, K., Annane, D., Lawrence, C., Gault, E., & De, P. (2022). Predictors of Nonseroconversion after SARS-CoV-2 Infection. Emerging Infectious Diseases, 28(2), 492-493. https://doi.org/10.3201/eid2802.211971. |
Volume 28, Number 1—January 2022

New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria
EID | Yao Y, Imirzalioglu C, Falgenhauer L, Chakraborty T. New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria. Emerg Infect Dis. 2022;28(1):265. https://doi.org/10.3201/eid2801.212106 |
---|---|
AMA | Yao Y, Imirzalioglu C, Falgenhauer L, et al. New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria. Emerging Infectious Diseases. 2022;28(1):265. doi:10.3201/eid2801.212106. |
APA | Yao, Y., Imirzalioglu, C., Falgenhauer, L., & Chakraborty, T. (2022). New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria. Emerging Infectious Diseases, 28(1), 265. https://doi.org/10.3201/eid2801.212106. |